Novavax (NVAX) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Novavax (NVAX) reported a Q4 loss of $0.51 per share, which is better than the Zacks Consensus Estimate of a $0.75 loss. This is an improvement from the $1.44 loss per share a year ago.
February 27, 2025 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novavax reported a Q4 loss of $0.51 per share, beating the Zacks Consensus Estimate of a $0.75 loss. This marks an improvement from the previous year's $1.44 loss per share.
The better-than-expected earnings report is likely to have a positive short-term impact on NVAX's stock price. Beating estimates and showing improvement from the previous year can boost investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100